NOT-OD-20-171: Notice of Correction to Eligibility in NIH Funding Opportunity Announcements

Notice of Correction to Eligibility in NIH Funding Opportunity Announcements

Notice Number:

NOT-OD-20-171

Key Dates

Release Date:

August 28, 2020

Related Announcements

PA-20-183 - Research Project Grant (Parent R01 Clinical Trial Required)

PA-20-184 - Research Project Grant (Parent R01 Basic Experimental Studies with Humans Required)

PA-20-185 - NIH Research Project Grant (Parent R01 Clinical Trial Not Allowed)

PA-20-194 - NIH Exploratory/Developmental Research Grant Program (Parent R21 Clinical Trial Required)

PA-20-195 - NIH Exploratory/Developmental Research Grant Program (Parent R21 Clinical Trial Not Allowed)

PA-20-196 - NIH Exploratory/Developmental Research Grant Program (Parent R21 Basic Experimental Studies with Humans Required)

PA-20-200 - NIH Small Research Grant Program (Parent R03 Clinical Trial Not Allowed)

PA-20-207 - NIH Support for Conferences and Scientific Meetings (Parent R13 Clinical Trial Not Allowed)

PAR-20-235 - Behavioral Tasks Targeting Brain Systems Relevant to Anhedonia (R01 Basic Experimental Studies with Humans Required)

PAR-20-241 - Large scale mapping and/or molecular profiling of ensembles and/or cell-types mediating opioid action in the rodent brain (R01 - Clinical Trial Not Allowed)

PAR-20-256 - Limited Competition Emergency Awards: Shared Personal Protective Equipment Resources for COVID-19 Related Vaccine and Treatment Clinical Trials and Clinical Studies (S10 Clinical Trial Not Allowed)

PAR-20-278 - NCI Outstanding Investigator Award (R35 Clinical Trial Not Allowed)

PAR-20-279 - Device-Based Treatments for Substance Use Disorders (UG3/UH3, Clinical Trial Optional)

PAR-20-284 - Innovative Research in Cancer Nanotechnology (IRCN) (R01 Clinical Trial Not Allowed)

PAR-20-285 - NIH StrokeNet Clinical Trials and Biomarker Studies for Stroke Treatment, Recovery, and Prevention (UG3/UH3 Clinical Trial Optional)

PAR-20-292 - NCI Clinical and Translational Exploratory/Developmental Studies (R21 Clinical Trial Optional)

PAR-20-294 - Core Infrastructure Support for Cancer Epidemiology Cohorts (U01 Clinical Trial Not Allowed)

RFA-DA-21-006 - BRAIN Initiative: Tools for Germline Gene Editing in Marmosets (U01 - Clinical Trial Not Allowed)

RFA-DA-21-009 - Interventions to Prevent Electronic Nicotine Delivery Systems (ENDS) Use Among Adolescents (R01 - Clinical Trial Optional)

RFA-DA-21-013 - Advancing HIV/AIDS Research through Computational Neuroscience FOA (R01 - Clinical Trial Optional)

RFA-DA-21-024 - PrEP for HIV Prevention among Substance Using Populations (R01 - Clinical Trial Optional)

RFA-DA-21-026 - Using Human Cell Animal Chimera Brains to Study HIV Latency and Pathology (R01 - Clinical Trials Not Allowed)

RFA-DE-21-001 - Characterizing causal mechanisms to prevent dental fear and anxiety (R01 Basic Experimental Studies with Humans Required)

RFA-DK-20-007 - Biomarkers of Dietary Intake and Exposure Coordinating Center (U24 Clinical Trial Not Allowed)

RFA-DK-20-011 - Caring for OutPatiEnts after Acute Kidney Injury (COPE-AKI) – Clinical Centers (U01 Clinical Trial Required)

RFA-DK-20-012 - Caring for OutPatiEnts after Acute Kidney Injury (COPE-AKI) – Scientific and Data Research Center (U01 Clinical Trial Required)

RFA-DK-20-016 - Continuation of the Human Pancreas Analysis Program (HPAP) for Type 1 Diabetes (HPAP-T1D) (U01 Clinical Trial Not Allowed)

RFA-DK-20-017 - Chronic Kidney Diseases of UnceRtain Etiology (CKDu) in Agricultural Communities (CURE) Research Consortium - Field Epidemiology Sites (U01 - Clinical Trial Not Allowed)

RFA-DK-20-018 - Chronic Kidney Diseases of UnceRtain Etiology (CKDu) in Agricultural Communities (CURE) Research Consortium – Renal Science Core (U01 - Clinical Trial Not Allowed)

RFA-DK-20-019 - Chronic Kidney Diseases of UnceRtain Etiology (CKDu) in Agricultural Communities (CURE) Research Consortium - Scientific Data Coordinating Center (SDCC) (U24 - Clinical Trial Not Allowed)

RFA-HL-21-003 - Regenerative Medicine Innovation Project (RMIP) Investigator-Initiated Clinical Trials (UG3/UH3 – Clinical Trial Required)

RFA-MH-20-600 - BRAIN Initiative: Data Archives for the BRAIN Initiative (R24 Clinical Trial Optional)

RFA-NS-20-031 - The NINDS Human Biospecimen and Data Repository (U24 Clinical Trial Not Allowed)

RFA-OD-20-016 - Emergency Awards: RADx-RAD Multimodal COVID-19 surveillance methods for high risk clustered populations (R01 Clinical Trial Optional)

Issued by

Office of The Director, National Institutes of Health (OD)

Purpose

NIH is announcing a correction to the following Funding Opportunity Announcements (FOAs) which reinstates 'Eligible Agencies of the Federal Government' and 'U.S. Territory or Possession' to the list of Eligible Organizations in Section III. Eligibility Information. Applicants are encouraged to review this section prior to submitting an application.